CONTENTS:
- Minimizing double standards in assessing the adverse and beneficial effects of cannabis [Editorial]. Hall W., Hoch E., p. 1606-1608.
- Is minimum unit pricing for alcohol having the intended effects on alcohol consumption in Scotland? [Addiction opinion and debate]. Holmes J., p. 1609-1616.
- Minimum unit pricing and the messiness of evidence-based policy. Bhattacharya A., p. 1617-1618.
- Disentangling the messiness of natural experiments to evaluate public policy. Robinson M., Callinan S., Taylor N., p. 1618-1620.
- A timely piece of global relevance, but shouldn't we move towards more real-world studies of the effect of multiple policy interventions and ongoing monitoring of alcohol policy impacts? Parry C.D.H., p. 1620-1621.
- When should we conduct large-scale evaluations? Holmes J., p. 1622-1623.
- Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis. Bharat C., Webb P., Wilkinson Z., McKetin R., Grebely J., Farrell M., et al., p. 1624-1648.
- A narrative systematic review of the gender inclusivity of measures of harmful drinking and their psychometric properties among transgender adults. Dermody S.S., Uhrig A., Moore A., Raessi T., Abramovich A., p. 1649-1660.
- Effect of cognitive-behavioral techniques for problem gambling and gambling disorder: A systematic review and meta-analysis. Pfund R.A., Forman D.P., Whalen S.K., Zech J.M., Ginley M.K., Peter S.C., et al., p. 1661-1674.
- Does polygenic risk for substance-related traits predict ages of onset and progression of symptoms? Kranzler H.R., Feinn R., Xu H., Ho B.L., Saini D., Nicastro O.R., et al., p. 1675-1686.
- Gaming disorder and stigma-related judgements of gaming individuals: An online randomized controlled trial. Galanis C.R., Weber N., Delfabbro P.H., Billieux J., King D.L., p. 1687-1698.
- Commentary on Galanis et al.: When age could make the difference - Let's not sweep violence under the keyboard. Luquiens A., Lopez Castroman J., p. 1699-1700.
- Evaluation of statewide restrictions on e-cigarette nicotine strength - United States, 2017-2022. Ali F.R.M., Schillo B., Crane E., Seaman E.L., King B.A., p. 1701-1709.
- Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial. Hitsman B., Papandonatos G.D., Gollan J.K., Huffman M.D., Niaura R., Mohr D.C., et al., p. 1710-1725.
- Alcohol's harm to others in 2021: Who bears the burden? Laslett A.M., Room R., Kuntsche S., Anderson-Luxford D., Willoughby B., Doran C., et al., p. 1726-1738.
- Identifying and describing trajectories of alcohol use frequency and binge drinking frequency among those aged 15-30 years in a national cohort of US adolescents: A group-based trajectory modeling approach. Ranker L.R., Ross C.S., Rudolph A.E., Weuve J., Xuan Z., p. 1739-1750.
- All-cause and cause-specific mortality in individuals with an alcohol-related emergency or hospital inpatient presentation: A retrospective data linkage cohort study. Leung J., Chiu V., Man N., Yuen W.S., Dobbins T., Dunlop A., et al., p. 1751-1762.
- Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis. Rivera Saldana C.D., Abramovitz D., Beletsky L., Borquez A., Kiene S., Marquez L.K., et al., p. 1763-1774.
- A guided digital intervention to reduce cannabis use: The ICan randomized controlled trial. Olthof M.I.A., Goudriaan A.E., van Laar M.W., Blankers M., p. 1775-1786.
- Impulsivity in amphetamine use disorder: Examination of sex differences. Stewart J.L., Burrows K., Davis C.B., Wilhelm R.A., McNaughton B.A., Kuplicki R., et al., p. 1787-1800.
- Prevalence of cannabis use among young adults in Sweden comparing randomized response technique with a traditional survey. Andersson F., Sundin E., Magnusson C., Ramstedt M., Galanti M.R., p. 1801-1810.
- Assessing and minimizing risk of bias in randomized controlled trials of tobacco cessation interventions: Guidance from the Cochrane Tobacco Addiction Group. Hartmann-Boyce J., Lindson N., p. 1811-1816.
- Commentary on Kumar et al.: The importance of conceptual clarity and alignment between constructs and measurements in social cognition research in addiction. Pabst A., Maurage P., p. 1819-1820.
- A response to Pabst and Maurage: In defense of empathy self-report measures. Creswell K.G., Kumar L., p. 1821-1822.